FDA Inspection 1177876 — Catalent Belgium SA

Catalent Belgium SA — FEI 3007647000

The FDA completed an inspection of Catalent Belgium SA on August 19, 2022 in Brussels. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 19, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Brussels (Belgium)